<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 318 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page317.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=318">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 318 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 318</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=318"><img src="../thumb/318.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Anti-Microbials - 18.12                                                        2020-04 / 281
       ther.when ser.psych.sympts.exper., poss. foet.harm.when admin.  pts.with patholog.bone fract. hist./at risk of osteopen., Ca & vit.D   conc. incr. with ritonavir, saquinavir conc.decr., didanosine conc.
       dur.1  trimest. theref. avoid pregn., barr.contracept.tog.with other   supplementat. poss benefic., cholesterol./ triglycerid. monit, pts.  incr., warfar.plasma conc.incr. /decr., carbamazepine/phenytoin/
         st
       methods recomm., elderly, concom. didanosine /atazanavir/lopina-  to seek med.advice if exper. joint pain/aches/stiffn./movem.diffic.  phenobarbit.& efavirenz conc.decr.with these anticonvuls., sertra-
       vir/ritonavir & discont. if advers.effs.develop., do not admin. con-  as osteonecros. poss., seiz.hist., period.plasma monit. of anticon-  line/ itraconazole/ketoconazole/ clarithromyc./ rifabutin/Ca chan.
       com. saquinavir as sole protease inhibit., no dos. recomm.for itra-  vuls. ther., eval.for signs of fat redistribut., CV risk assessm.with   block./HMG-CoA reduct. inhibit.& methadone plasma conc.decr.,
       conazole avail.theref.seek alt. antifung., rash report.with efavirenz   evid.of lipodystrophy, immune reconstit.syndr., opportunist. in-  rifampicin decr.efavirenz conc., ethinyl oestrad. conc.incr.
       & clarithromycin theref.consid.alt.eg.azithromycin, combinat.with   fects & other HIV complicat.still poss., ther.not proven to prev.HIV
       other macrolides not stud., seiz. hist., period.plasma monit.of an-  transmiss. through sex.cont./bld.contam., elderly, perf.pregn. test   TRIONCE, (Forrester) Emcure [P/S]
       ticonvuls.ther., discont. ther.with sev.skin rash assoc.with blister./   in women of childbear.age prior to init.ther., barr. contracept.tog.  Efavirenz 600 mg, emtricitabine 200 mg, tenofovir disoproxil fu-
       desquamat./mucos.involvem.& fev., eval. risk vs.benef.of cont.  with other methods recomm. dur.& for 12 wks.aft.discont.treatm,   marate 300 mg.
       ther.if ser. transaminase. lev.persist.5x&gt;ULN, monit.BMD in pts.   concom. didanosine/ atazanavir or lopinavir/ritonavir & discont. if   Indications: HIV-1 infect.treatm.in adults alone as complete regi-
       with patholog.bone fract. hist./at risk of osteopen., Ca & vit.D sup-  advers.effs.develop, addit.ritonavir. recomm. with concom.fosam-  men or in combinat.with other anti-retrovir.
       plementat.poss benefic., lact.intol.  prenavir, decr.anti-malar. effic.of concom.artemether/lumefantrine,   (S4) TABS, 50/20.2.8/0180
       Drug interactions: Poss.addit.CNS effs.with alcoh. /psychoact.  do not admin. concom.saquinavir as sole protease inhibit., monit.liv   723676-001: 30, R488,05
       meds., plasma conc.of other compds. that are CYP3A4 substrat.  enzym.with concom.meds. assoc. wih hepat.toxic./known or sus-  Dosage: Adults: 1 tab.once dly.on empty stomach. Bedt.dos.may
       poss.decr., meds. induc.CYP3A4 activ.incr.clear., ser.conc.of drugs   pect. HVB/C, no dos. recomm.for itraconazole avail.theref.seek alt.   improv.CNS sympt. tolerabil.
       elimin.by act.tubul.secret.may incr., atazanavir & lopinavir/ritonavir   antifung., rash report.with efavirenz & clarithromycin theref.con-  Contraindications: Concur.astemizole/bepridil/ cisapride/ mida-
       incr.tenofovir conc., reduc.efavirenz conc.with St John’s Wort ex-  sid.alt.eg.azithromycin, combinat.with other macrolides not stud.  zolam/pimozide/triazolam/ergot derivat. & voriconazole, mod-sev.
       pect., amprenavir ser.conc.decr., atazanavir conc. decr., metabol.of   Interactions: Reduc.NNRTI conc.with St John’s Wort expect., poss.  ren.impairm., sev. hepat.impairm /prev.liv.injury hist
       indinavir incr., ritonavir & efavirenz conc. incr.with ritonavir, saqui-  addit.CNS effs.with alcoh. /psychoact.meds., plasma conc.of other   Side effects: Freq: Anorex., neutropen., allerg. react., hypertri-
       navir conc. decr., didanosine conc.incr., warfarin plasma conc.incr./  compds. that are CYP3A4 substrat.poss.decr., meds.induc. CYP3A4   glyceridaem., hyperglycaem., hypophosphataem., depress., anx.,
       decr., carbamazepine/ phenytoin/ phenobarbit. & efavirenz conc.  activ.incr.clear., incr.expos.with inhibit.of CYP3A4 or CYP2B6/ grape-  abnorm. dreams, insomn., cerebell.coordinat. & bal. disturbs., som-
       decr. with these anticonvuls., sertraline/itraconazole/ ketocona-  fruit juice, conc.of emtricitabine/tenofovir/concom.med incr. with   nol., headache, attent.disturb., dizzin., elev. AST/ALT/GGT, hyper-
       zole/clarithromyc./rifabutin/ Ca chan. block. /HMG-CoA reduct.   concom. drugs elim.by glomerul.& act.tubul. secret./ decr.ren. funct,   bilirubinaem., incr. transaminas., elev. creatine kinase, rash, prurit.,
       inhibit.& methadone plasma conc.decr., rifampicin decr.efavirenz   atazanavir conc.decr., atazanavir incr.tenofovir conc., amprenavir ser.   urticar., skin discolour., fatig., pain, asthen. Less freq: Dry mouth,
       conc., ethinyl oestrad.conc.incr.  conc. decr., metabol.of indinavir incr., tenofovir conc. incr.with lopi-  incoher.speech, incr.appet., decr. libido & myalgia, anaem., hyper-
                                                                  sens., hypercholesterolaem., hypokalaem., lactic acidos., suicide
       TRIEMTA, (Activo) Macleods, [P/S]  navir/ritonavir combinat., lopinavir conc.decr., ritonavir & efavirenz   attempt/ideat., psychos., mania, paran., hallucin., euphor.mood,
                                     conc. incr. with ritonavir, saquinavir conc.incr., didanosine conc.incr.,
       Efavirenz 600 mg, emtricitabine 200 mg, tenofovir disoproxil fu-  warfar.plasma conc.incr. /decr., carbamazepine/phenytoin/pheno-  affect lability, confus. state, aggress., suicide, delus., neuros., con-
       marate 300 mg.                barbit.& efavirenz conc.decr.with these anticonvuls., sertraline/   vuls., amnes., abnorm.think./coordinat., atax., agitat., trem., blurr.
       Indications: Mono- or combinat.ther.for HIV-1 infect. in adults  itraconazole/ketoconazole/ posaconazole/ clarithromyc./rifabutin/  vis., tinnit., vertigo, flush., diarrh., naus., elev. amylase incl. elev.
       (S4) TABS, 51/20.2.8/0121.120  Ca chan. block./HMG-CoA reduct.inhibit plasma conc.decr., meth-  pancreat.amylase/ ser. lipase, vomit., abdom.pain/distens., dys-
       3000260-001: 30, R241,50      adone plasma lev.decr. result.in opiate withdr. signs in HIV infect.  peps., flatul., pancreatit., ac.hepatit., hepat.fail., hepat. steatos.,
       Dosage: Adults: 1 tab.once dly.on empty stomach. Bedt.dos.may   IV drug users, rifampicin decr.efavirenz conc., ethinyl oestrad.conc.  Stev-Johns.syndr., erythema multiforme, sev. rash, photoallerg.
       improv.CNS sympt. tolerabil.  incr., artemether/lumefantrine & efavirenz conc.decr. with concom.  dermatit., angioed., rhabdomyolys., musc.weakn., osteomalac.,
       Contraindications: Concom.astemizole/bepridil/ cisapride/ mi-  use, conc.of atovaquone & proguanil decr.  myopathy, incr. creatinine, proteinur., ren.fail., acute tubul.necros,,
       dazolam/pimozide/ triazolam/ergot derivat/ St John’s Wort., con-  proxim.ren.tubulopathy incl. Fanconi syndr., nephrit., nephrogen.
       com.voriconazole, mod.-sev.ren.impairm., sev.hepat.impairm., hist.  TRIOLAR, (Activo) Macleods, [P/S]  diabet, insipid., gynaecomast.
       of prev. liv.inj./fail.with efavirenz contain.meds., concom. meds/  Efavirenz 600 mg, emtricitabine 200 mg, tenofovir disoproxil fu-  Warnings and special precautions: Safety & effic. in pts.with
       combinat.contain lamivudine, safety & effic.in pts.less than 18 yrs.  marate 300 mg.  both HIV & hepatit.B not est., monit. hepat.funct.for sev.mnths.
       not est., pregn. & lactat.    Indications: Mono- or combinat.ther.for HIV-1 infect. in adults  in pts.co-infect. with HIV & HBV who discont.ther.& appropr.init.
       Side effects: Efavirenz: Freq:  Weight gain, hypertriglyceridem.,   (S4) TABS, 47/20.2.8/1006  of anti-hepatit.B ther.poss.necess., obesity & prolong. nucleoside
       GI disords., elev.AST/ALT/ GGT, depress., anx., abnorm.dreams, in-  721497-001: 30, R466,00  use poss.risk fact.for lact. acidos., liv.dis.risk fact., discont.if find.
       somn., dizzin., headache, somnol., cerebell. coordinat./bal.disturb.,   Dosage: Adults: 1 tab.once dly.on empty stomach. Bedt.dos.may   suggest. lact. acidos./hepatotoxic., investig.child.expos.in utero to
       attent.disturb, diffuse maculopapul.rash, prurit., fatig. Less freq:   improv.CNS sympt. tolerabil.  nucleoside & nucleotide analog.for poss. mitochondr.dysfunct.in
       Hypersens., hypercholesteraem, stupor, confus., imp. conc., abnorm.  Contraindications: Concom.astemizole/ bepridil/ cisapride/mida-  case of relev.S&S, consid. pancreatit.if pt. devel. abdom.pain/N&V/
       think./vis., agitat., amnes., delir., emot.lability, euphor., hallucin.,   zolam/pimozide/triazolam/ergot derivat/ St John’s Wort., concom.  elev. biochemic. markers & discont.until diagnos.of pancreatit. excl.,
       psychos., suicide attempt/ideat./complet., paranoia, mania, delus.,   voriconazole, mod.-sev.ren.impairm., safety & effic.not est.in hepatit.   safety & effic.not est.in pts.with signific. underly.liv.disords./dis.,
       neuros., blurr.vis., tinnit., vertigo, palpitat., tachycard., flush., asthma,   B vir.co-infects., concom.meds/combinat. contain lamivudine, safety   monit.liv.funct.in pts. with pre-exist.liv.dysfunct., discont.in case of
       URTI, sinusit., gastrit., gastroenterit., gastro-oesophag.reflux, incr.  & effic.in pts.less than 18 yrs.not est., pregn. & lactat.  exacerb. of liv.dis., pts.with chron.hepatit. B/C treat. with antiretro-
       appet., taste pervers., pancreatit., hepatit., hepat.fail., sev. rash with   Side effects: Lactic.acidos.& sev.hepatomegaly with steatos.incl.  vir.ther.are at incr. risk for sev. & potent.fatal hepat.adverse reacts.,
       blister., moist desquamat., ulcerat., acne, alopec., eczema, folliculit.,   fatal., sev.ac.exacerbat.of hepatit B aft.discontinuat., ser.psych.  also consult prod. lit.of concom.antiviral ther.for hepatit.B/C, sev.
       seborrh., skin exfoliat., urticar., erythema multiforme, photoallerg.   sympts.incl. sev. depress./ suicid.ideat./non fat.suicide attempts   ac. exacerbat.of hepatit.B aft.discont.of emtricitabine/ tenofovir,
       dermatit., Stev.-Johns.syndr., arthralg., myalg., impot., decr./incr.  / aggress.behav./paranoid & manic reacts., CNS sympts. incl.hal-  eval.for signs of fat redistrib., CV risk assessm.in pts.with evid.of
       libido, gynaecomast., asthen., malaise, pain, syncope, influenza-  lucin./abnorm.think.& depersonalisat. which gen.improv.with cont.  lipodystrophy, immune reconstitut.syndr., pts.to seek med. advice
       like sympts., alcoh.intoler., hot flush., abnorm. coordinat., atax.,   ther., ren. impairm.incl.ac.ren.fail., skin rash, pain, GI disturbs., pan-  if experienc.joint pain/aches/ stiffn./ movem.diffic.as osteonecros.
       convuls., migraine headaches, neuralg., paraesthes., periph. neu-  creatit., arthralg., back/chest pain, incr. cough, fev.,bld.dyscras.,   poss., monit. BMD in pts.with patholog. bone fract.hist./at risk of
       ropathy, speech disord., trem., hypoaesthes., amnes., agitat. Freq.  myalg., paraesthes., periph. neuropathy/-neurit., pneumon., rhinit.,   osteopen., opportunist. infects & other HIV complicat. still poss.,
       not known: Immuno-allerg. liv. inj./fail., weight loss, redistribut./  hyperpigmentat. of palms &/soles, fatig., asthma, URTI, influenza-  ther.not proven to prev.HIV transmiss. through sex.cont./bld.con-
       accumulat.of body fat, inappropr.behav., apathy, dyspn., constip., ma-  like sympts., incr.lipid conc., palpitat., tinnit., vertigo, gynaecomast.,   tam., contin. approp. precaut.prevent.HIV transmiss.risk, do not
       labsorpt., nail disord., skin discolourat., myopathy. Emtricitabine:   libido chang., abnorm.vis., GI malabsorpt., hepatobil. disords., allerg.  use concom. lamivudine/meds.contain.lamivudine, concom.St
       Freq.: Allerg. react., elev.creatine kinase/AST/ALT/ amylase/ ser.  reacts., weight chang., body fat redistribut./accumulat., myopathy,   Johns Wort not recomm., treatm. discont. poss.reqd.if ser.psych.
       lipase , hyperbilirubinaem., headache, dizzin., hyperglycaem., hy-  asthen., malaise, syncope, abnorm.co-ordinat., atax., convuls., hy-  sympt.exper., determ. creatin.clear.bef.init.& dur.ther., ren. funct./
       pertriglyceridem, GI disords. neutropen, pain, asthen., rash, skin   poaesthes., trem., dyspn., flush., tachycard., erythema multiforme,   ser.phosphate monit.in pts.at risk/hist.of ren. dysfunct., avoid with
       discolourat., sleep disturbs. Less freq: Anaem., angioed. Freq not   Stev.-John. syndr., nail disords., photoallerg.dermatit., osteomalac.,   concom./rec.nephrotox. agents, safety & effic.in pts.less than 18
       known: Arthralg., myalg., depress.disord., lact.acidos. assoc. with   lumb.spine/hip & both arms BMD decr. from baseline, convuls.,   yrs.not est., elderly, not recomm.in mod.to sev.hepat. impairm.,
       sev.hepatomeg.& steatos., incr.cough, rhinit., asthen., neuropathy,   inflamm.respons.to indolent/ resid.infects.necessit.furth.eval.&   seiz/psych.disord. hist., discont.ther.with sev.skin rash assoc. with
       periph.neurit., paraesthes. Tenofovir: Freq.: Hypophosphataem.,   treatm., alcoh.intol., hypophosphataem., hyperglycaem.  blister./desquamat./ mucos.involvem.& fev., monit.ser.lipids & bld.
       GI disords., inr. transaminas., skin rash. Less freq.: Hypokalaem.,   Warnings and special precautions: Monit. hepat. funct.for   gluc., poss.false-posit.results in urin.cannabinoid tests, pregn.
       lact.acidos.assoc.with sev. hepatomeg. & steatos., rais.ser.am-  sev.mnths.in pts.co-infect.with HIV & HBV & discont.ther., obesity   as foet.harm.poss., women of child-bear. potent.should undergo
       ylase conc., pancreatit., hepat. steatos., hepatit., angioed. Freq.   & prolong. nucleoside use poss.risk fact.for lact.acidos., liv. dis.   pregn.test.bef.init. ther., barr.contracept.tog.with other methods
       not known: Neutropen., haematur., hypertriglyceridaem., hyper-  risk fact., discont.if find.suggest.lact.acidos./ hepatotoxic., test for   recomm., lactat., poss.incr.didanosine-relat. adverse eff., monit.
       glycaem., depress., anx., periph.neuropathy, chest pain, pneumon.,   chron.hepatit.B bef.init.ther., immed. risk vs. benefit eval.of cont.  for tenofovir-assoc.adv.events with concom. lopinavir/ritonavir,
       dyspn., allerg.react.         ther.when ser. psych. sympts.exper., determ.creatin.clear. bef. init.  monit.liv. enzym. with concom.ritonavir, do not admin.concom.
       Warnings and special precautions: Not indic. for treatm.of   ther., avoid with concom./rec.nephrotox. agents, pts at risk of ren.  saquinavir as sole protease inhibit., concom.Ca chann. blocks.dos.
       chron.hepatit.B infect., safety & effic. not est.in HBV & HIV co-  impairm.perf.pregn.test in women of childbear.age prior to init.ther.,   adjustm.guid.by clinic.respons.
       infects., monit.hepat. funct. for sev.mnths.in pts.co-infect.with   barr. contracept.tog.with other methods recomm., elderly, concom.  Interactions: Reduc.NNRTI conc.with St John’s Wort expect., ad-
       HIV & HBV who discont.ther.& appropr.init.of anti-hepatit. B ther.  didanosine/atazanavir/lopinavir & discont.if advers.effs.develop,   dit.CNS effs.with alcoh./ psychoact. meds., food may incr.expos.to
       poss.necess., obesity & prolong. nucleoside use poss.risk fact.for   addition.ritonavir. recomm.with concom.fosamprenavir , do not   efavirenz & incr.adv.effect freq., plasma conc.of other compds. that
       lact.acidos., liv. dis. risk fact., discont.in clinic./lab.find. suggest.   admin. concom.saquinavir as sole protease inhibit., monit.liv en-  are CYP3A4 substrat.poss.decr., CYP3A4 induc.incl.phenobarbitone/
       lact.acidos./hepatotox., investig.childr.expos.in utero to nucleo-  zym.with concom.meds. assoc.wih hepat.toxic./known or suspect.   rifampicin/ rifabutin incr.efavirenz clear., conc.of drugs reduc. ren.
       side & nucleotide analog.for poss. mitochondr. dysfunct.in case   HVB/C, no dos.recomm.for itraconazole avail.theref.seek alt. anti-  funct./elim.by act.tubul.secret.may be incr., atazanavir conc.decr.,
       of relev.S&S, discont. ther. until pancreatit.excl.in cases of N&V/  fung., rash report.with efavirenz & clarithromycin theref.consid.alt.  atazanavir incr.tenofovir conc., amprenavir ser.conc.decr., metabol.of
       abdom. pain/ elev.biochem.mark., safety & effic.not est.in signif-  eg.azithromycin, combinat.with other macrolides not stud., monit.   indinavir incr., tenofovir conc.incr.& lopinavir conc. decr. with lopinavir
       ic. underly.liv. disords., monit.liv.funct.with pre-exist.liv.dysfunct.,   BMD in pts.with patholog.bone fract.hist./at risk of osteopen., Ca   /ritonavir, ritonavir & efavirenz conc. incr.with ritonavir, saquinavir
       cons. ther.interrupt./discont. if evid.of worsen.liv.dis., ref.to PI of   & vit.D supplementat.poss benefic., seiz. hist., period.plasma monit.  conc.decr., didanosine conc.incr., warfar.plasma conc. incr./ decr.,
       concom.hepat. B or C meds, monit.liv.enzymes partic.in known/   of anticonvuls. ther., discont.in case of sev.skin rash, immune recon-  carbamazepine/phenytoin/ phenobarbit. conc.decr., carbamazepine
       suspect. hepatit.B/C infect.hist./concom.hepatotox meds., eval.risk   stit. syndr., opportunist.infects & other HIV complicat. still poss.,   incr.efavirenz conc., phenytoin/ phenobarbit.decr.efavirenz conc.,
       vs.benef.of cont.ther.if ser. transaminase.lev.persist.5x&gt;ULN, reg.  ther.not proven to prev.HIV transmiss.through sex.cont./bld.contam.  sertraline/ itraconazole/ketoconazole/ clarithromyc./ rifabutin/Ca
       test.for jaund./ bleed tend., test for chron.hepatit.B bef. init. ther.,   Interactions: Reduc.NNRTI conc.with St John’s Wort expect., poss.  chan.block./HMG-CoA reduct. inhibit.& methadone plasma conc.
       sev.ac.exacerbat.of hepatit.B aft. discont., immed.risk vs. benefit   addit.CNS effs.with alcoh. /psychoact.meds., plasma conc.of other   decr., rifampicin decr.efavirenz conc., ethinyl oestrad. conc.incr.
       eval.of cont.ther. when ser.psych.sympts.exper., do not admin.in   compds. that are CYP3A4 substrat.poss.decr., meds. induc. CYP3A4
       pts. with creatin.clear.&lt; 50 ml/min, determ.creatin. clear. bef.init./  activ.incr.clear., ser.conc.of drugs elimin. by act.tubul.secret.may incr.,   TRIPLAVAR, Cipla Medpro [P/S]
       dur.ther., avoid with concom./rec. nephrotox. agents, pts at risk of   atazanavir conc.decr., atazanavir incr.tenofovir conc., amprenavir ser.   Lamivudine 150 mg, zidovudine 300 mg, nevirapine 200 mg
       ren.impairm., antihistam./corticoster.for mild to mod.rash to improv.   conc. decr., metabol.of indinavir incr., tenofovir conc. incr.with lopi-  Indications: HIV-1 infect.once pt.complet.2 wk. lead-in period on
       tol.& resolv.rash, discont.in case of sev. skin rash, monit. BMD in   navir /ritonavir combinat., lopinavir conc.decr., ritonavir & efavirenz   the 3 indiv.compon. OR once pt. stabilis.on indiv.compon.in same dos.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page317.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page313.html">313</a>&nbsp;&nbsp;&nbsp;<a href="page314.html">314</a>&nbsp;&nbsp;&nbsp;<a href="page315.html">315</a>&nbsp;&nbsp;&nbsp;<a href="page316.html">316</a>&nbsp;&nbsp;&nbsp;<a href="page317.html">317</a>&nbsp;&nbsp;&nbsp;<a href="page318.html">318</a>&nbsp;&nbsp;&nbsp;<a href="page319.html">319</a>&nbsp;&nbsp;&nbsp;<a href="page320.html">320</a>&nbsp;&nbsp;&nbsp;<a href="page321.html">321</a>&nbsp;&nbsp;&nbsp;<a href="page322.html">322</a>&nbsp;&nbsp;&nbsp;<a href="page323.html">323</a>
             </td>
             <td width="35%"><a href="page319.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page319.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
